Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy by Uma Ramaswami, Guillem Pintos-Morell, Christoph Kampmann, Kathleen Nicholls, Dau-Ming Niu, Ricardo Reisin, Michael L. West, Christina Anagnostopoulou, Jaco Botha, Dalia Jazukeviciene, Jörn Schenk, Derralynn A. Hughes, Roberto Giugliani

Get full text